ReviewCell insight2026
Circadian mechanisms in heart failure: Cell-specific regulation and chrono-medicine.
Review in Cell insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging evidence indicates that circadian rhythms profoundly influence the pathophysiology of heart failure (HF). The circadian clock system governs myocardial functions via synchronized actions from multiple cell types involving cardiomyocytes and non-cardiomyocytes. This review summarizes state-of-the-art advances on the cardiovascular circadian system and provides a perspective on time-of-day effects in the pathophysiology of HF, including energy metabolism, tissue inflammation and fibrosis. In particular, we focus on cell-specific circadian regulation and synthesize how circadian clocks across cardiomyocytes, vascular cells, fibroblasts, and adipocytes interact to regulate the pathophysiology of HF. Based on this framework, we discuss how synchronizing internal and external time cues via clock-modulating compounds and/or time-restricted eating (TRE) may prevent HF or facilitate rehabilitation. Together, this Review provides a timely synthesis of current understanding of HF as a function of biological timing and highlights potential chronotherapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.